Stoke Therapeutics, Inc. (STOK) Common Stock, Shares, Outstanding 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Stoke Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from 2018 to 2024.
  • Stoke Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 46.5 M shares, a 5.26% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 46.5 M +2.32 M +5.26% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 45.9 M +6.48 M +16.4% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 44.3 M +4.87 M +12.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 44.2 M +4.82 M +12.2% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 44.2 M +5.13 M +13.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 39.4 M +2.54 M +6.88% Dec 31, 2022 10-K 2024-03-25
Q3 2022 39.4 M +2.65 M +7.19% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 39.4 M +2.66 M +7.24% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 39 M +2.35 M +6.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 36.9 M +325 K +0.89% Dec 31, 2021 10-K 2023-03-06
Q3 2021 36.8 M +3.42 M +10.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 36.7 M +3.51 M +10.6% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.7 M +3.73 M +11.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 36.6 M +3.72 M +11.3% Dec 31, 2020 10-K 2022-03-10
Q3 2020 33.4 M +637 K +1.95% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 33.2 M +538 K +1.65% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 33 M Mar 31, 2020 10-Q 2020-05-15
Q4 2019 32.9 M +32.1 M +4418% Dec 31, 2019 10-K 2021-03-09
Q3 2019 32.7 M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 32.7 M Jun 30, 2019 10-Q 2019-08-14
Q4 2018 727 K Dec 31, 2018 10-K 2020-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.